Expression of Selenium-containing Proteins in Human Colon Carcinoma Tissue

V. Yagublu, J. R. Arthur, S. N. Babayeva, F. Nicol, S. Post, M. Keese

    Research output: Contribution to journalArticle

    16 Citations (Scopus)

    Abstract

    Selenium may be beneficial in reducing the risk of cancer incidence and mortality in many cancer types such as liver, prostate, colorectal and lung. However, despite the extensive recent research on selenium and selenium-containing proteins, there are still open questions concerning their expression in certain human cancer types, including colorectal carcinoma. Therefore, the expression level of the selenoproteins thioredoxin reductases 1 and 2 (TRXR-1 and TRXR-2) and glutathione peroxidases 1 and 4 (GPX1 and GPX4) in human colon carcinoma tissues was investigated. Up-regulation of TRXR-1 in the colon carcinoma specimens was found both in disease stage-dependent and independent analyses. No differences were found for TRXR-2 expression levels. GPX1 was up-regulated in carcinoma tissues at both the protein and mRNA levels. GPX4 was also up-regulated at the protein level, except for the samples derived from stage 111 patients. The expression of TRXR-1, GPX1 and GPX4, but not TRXR-2 is differently regulated in cancer as compared to healthy colonic tissue.

    Original languageEnglish
    Pages (from-to)2693-2698
    Number of pages6
    JournalAnticancer Research
    Volume31
    Issue number9
    Publication statusPublished - Sep 2011

    Keywords

    • Selenoprotein
    • colon cancer
    • glutathione
    • thioredoxin
    • antioxidant enzyme expression
    • thioredoxin reductase
    • glutathione-peroxidase
    • cancer prevention
    • colorectal-cancer
    • molecular target
    • cell-growth
    • system
    • selenoproteins
    • mechanism
    • therapy

    Cite this

    Yagublu, V., Arthur, J. R., Babayeva, S. N., Nicol, F., Post, S., & Keese, M. (2011). Expression of Selenium-containing Proteins in Human Colon Carcinoma Tissue. Anticancer Research, 31(9), 2693-2698.

    Expression of Selenium-containing Proteins in Human Colon Carcinoma Tissue. / Yagublu, V.; Arthur, J. R.; Babayeva, S. N.; Nicol, F.; Post, S.; Keese, M.

    In: Anticancer Research, Vol. 31, No. 9, 09.2011, p. 2693-2698.

    Research output: Contribution to journalArticle

    Yagublu, V, Arthur, JR, Babayeva, SN, Nicol, F, Post, S & Keese, M 2011, 'Expression of Selenium-containing Proteins in Human Colon Carcinoma Tissue', Anticancer Research, vol. 31, no. 9, pp. 2693-2698.
    Yagublu V, Arthur JR, Babayeva SN, Nicol F, Post S, Keese M. Expression of Selenium-containing Proteins in Human Colon Carcinoma Tissue. Anticancer Research. 2011 Sep;31(9):2693-2698.
    Yagublu, V. ; Arthur, J. R. ; Babayeva, S. N. ; Nicol, F. ; Post, S. ; Keese, M. / Expression of Selenium-containing Proteins in Human Colon Carcinoma Tissue. In: Anticancer Research. 2011 ; Vol. 31, No. 9. pp. 2693-2698.
    @article{e50b9be98bad4dbeb62f600ac9a2dba8,
    title = "Expression of Selenium-containing Proteins in Human Colon Carcinoma Tissue",
    abstract = "Selenium may be beneficial in reducing the risk of cancer incidence and mortality in many cancer types such as liver, prostate, colorectal and lung. However, despite the extensive recent research on selenium and selenium-containing proteins, there are still open questions concerning their expression in certain human cancer types, including colorectal carcinoma. Therefore, the expression level of the selenoproteins thioredoxin reductases 1 and 2 (TRXR-1 and TRXR-2) and glutathione peroxidases 1 and 4 (GPX1 and GPX4) in human colon carcinoma tissues was investigated. Up-regulation of TRXR-1 in the colon carcinoma specimens was found both in disease stage-dependent and independent analyses. No differences were found for TRXR-2 expression levels. GPX1 was up-regulated in carcinoma tissues at both the protein and mRNA levels. GPX4 was also up-regulated at the protein level, except for the samples derived from stage 111 patients. The expression of TRXR-1, GPX1 and GPX4, but not TRXR-2 is differently regulated in cancer as compared to healthy colonic tissue.",
    keywords = "Selenoprotein, colon cancer, glutathione, thioredoxin, antioxidant enzyme expression, thioredoxin reductase, glutathione-peroxidase, cancer prevention, colorectal-cancer, molecular target, cell-growth, system, selenoproteins, mechanism, therapy",
    author = "V. Yagublu and Arthur, {J. R.} and Babayeva, {S. N.} and F. Nicol and S. Post and M. Keese",
    year = "2011",
    month = "9",
    language = "English",
    volume = "31",
    pages = "2693--2698",
    journal = "Anticancer Research",
    issn = "0250-7005",
    publisher = "International Institute of Anticancer Research",
    number = "9",

    }

    TY - JOUR

    T1 - Expression of Selenium-containing Proteins in Human Colon Carcinoma Tissue

    AU - Yagublu, V.

    AU - Arthur, J. R.

    AU - Babayeva, S. N.

    AU - Nicol, F.

    AU - Post, S.

    AU - Keese, M.

    PY - 2011/9

    Y1 - 2011/9

    N2 - Selenium may be beneficial in reducing the risk of cancer incidence and mortality in many cancer types such as liver, prostate, colorectal and lung. However, despite the extensive recent research on selenium and selenium-containing proteins, there are still open questions concerning their expression in certain human cancer types, including colorectal carcinoma. Therefore, the expression level of the selenoproteins thioredoxin reductases 1 and 2 (TRXR-1 and TRXR-2) and glutathione peroxidases 1 and 4 (GPX1 and GPX4) in human colon carcinoma tissues was investigated. Up-regulation of TRXR-1 in the colon carcinoma specimens was found both in disease stage-dependent and independent analyses. No differences were found for TRXR-2 expression levels. GPX1 was up-regulated in carcinoma tissues at both the protein and mRNA levels. GPX4 was also up-regulated at the protein level, except for the samples derived from stage 111 patients. The expression of TRXR-1, GPX1 and GPX4, but not TRXR-2 is differently regulated in cancer as compared to healthy colonic tissue.

    AB - Selenium may be beneficial in reducing the risk of cancer incidence and mortality in many cancer types such as liver, prostate, colorectal and lung. However, despite the extensive recent research on selenium and selenium-containing proteins, there are still open questions concerning their expression in certain human cancer types, including colorectal carcinoma. Therefore, the expression level of the selenoproteins thioredoxin reductases 1 and 2 (TRXR-1 and TRXR-2) and glutathione peroxidases 1 and 4 (GPX1 and GPX4) in human colon carcinoma tissues was investigated. Up-regulation of TRXR-1 in the colon carcinoma specimens was found both in disease stage-dependent and independent analyses. No differences were found for TRXR-2 expression levels. GPX1 was up-regulated in carcinoma tissues at both the protein and mRNA levels. GPX4 was also up-regulated at the protein level, except for the samples derived from stage 111 patients. The expression of TRXR-1, GPX1 and GPX4, but not TRXR-2 is differently regulated in cancer as compared to healthy colonic tissue.

    KW - Selenoprotein

    KW - colon cancer

    KW - glutathione

    KW - thioredoxin

    KW - antioxidant enzyme expression

    KW - thioredoxin reductase

    KW - glutathione-peroxidase

    KW - cancer prevention

    KW - colorectal-cancer

    KW - molecular target

    KW - cell-growth

    KW - system

    KW - selenoproteins

    KW - mechanism

    KW - therapy

    M3 - Article

    VL - 31

    SP - 2693

    EP - 2698

    JO - Anticancer Research

    JF - Anticancer Research

    SN - 0250-7005

    IS - 9

    ER -